苦求癌症治愈法？答案就是你自己!

  说起癌症对我们而言并不陌生，在过去40年里癌症的存活率在英国增加了一倍，相同时期内来自南安普顿大学的研究人员同时也在研究抵御癌症的利器—我们机体的免疫系统；研究者Martin Glennie教授表示，超过90%的进行免疫疗法的癌症患者至少都存活了2年。
  免疫疗法是一种革命性的疗法，其可以通过向机体天然防御机体加压去帮助寻找癌细胞并且杀灭癌细胞，这种革命性的疗法可以治疗100多种不同类型的疾病；研究者指出，免疫疗法不仅可以破坏可见的癌细胞，而且可以帮助寻找并且清楚隐藏在机体其它部位深处的癌细胞。
  这种新型疗法是以疫苗和抗体的形式来直接指挥特殊的免疫细胞去抵御癌症，这些杀伤性细胞可以控制并且杀灭癌细胞，给予机体长效的保护机制。利用药物进行恶性及晚期癌症临床试验，比如肺癌、皮肤癌等，研究者发现效果非常显著，因此研究者表示，这种新型疗法或许可以搬出实验室，在临床试验中直接对患者进行研究。
  在南安普顿大学进行了超过40年的免疫学研究，研究者主要发现了：1）抗体疗法可以将白血病细胞从正常血液细胞中移除出来；2）一种DNA癌症疫苗；3）一种适用于成年人白血病的新型抗淋巴瘤抗体；4）易普利姆玛（Ipilimumab）作为一种被批准的免疫药物可以延长黑色素瘤患者的生命。
  本文中研究者的研究显示，新型疗法使得近乎一般难以治疗的癌症患者的症状都得到了明显的改善，几乎20%的患者都得到了治愈；有超过90%的利用免疫疗法治疗的患者在无癌状态下都生存了超过2年。后期研究将全面揭开治疗癌症的免疫学疗法的世界，研究者希望进行癌症免疫疗法的患者数量加倍，同时也希望这种新型免疫疗法可以明显改善其病情，后期研究人员将继续深入研究来加速开发更多新型的免疫疗法，从而更加快速有效地治疗患癌的患者。（转化医学网360zhyx.com）
  以上为转化医学网原创翻译整理，谢绝转载。如需转载，请联系 info@360zhyx.com
转化医学网推荐的新闻阅读：

In the last 40 years cancer survival in the UK has doubled and during that same time period researchers at the University of Southampton have looked more closely at, perhaps, the best weapon we have against cancer – our own immune system.

"More than 90 per cent of patients treated with immunotherapy who have survived more than two years remain cancer free."

Professor Martin Glennie, Head of Cancer Sciences

Immunotherapy is a revolutionary treatment that supercharges the body’s natural defences to find and destroy cancer with the potential to treat 100 different types of the disease. Immunotherapy treatments developed at Southampton not only destroy visible cancer cells but also seek out and eradicate hidden cancers in other parts of the body. Potentially, they give our bodies a lifetime of immunity with many of our patients who were previously given months to live now living cancer free.

“Our new treatments in the form of vaccines and antibodies direct special immune cells against cancers. These ‘killer’ cells can control and shrink cancer and give long-lasting protection,” says Peter Johnson, Professor of Medical Oncology.

Our clinical trials of drugs for advanced and terminal cancers, such as lung, skin (melanoma) and pancreatic cancers, and neuroblastoma, are showing remarkable results. Groundbreaking discoveries, such as vaccines, are moving out of the lab and reaching patients......